Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-059745
Filing Date
2025-06-30
Accepted
2025-06-30 17:14:25
Documents
13
Period of Report
2025-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0247555-8ka1_180life.htm   iXBRL 8-K/A 78743
  Complete submission text file 0001213900-25-059745.txt   304901

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20250612.xsd EX-101.SCH 3798
3 XBRL DEFINITION FILE atnf-20250612_def.xml EX-101.DEF 26636
4 XBRL LABEL FILE atnf-20250612_lab.xml EX-101.LAB 36679
5 XBRL PRESENTATION FILE atnf-20250612_pre.xml EX-101.PRE 25260
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0247555-8ka1_180life_htm.xml XML 7089
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38105 | Film No.: 251093181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)